Private company

Ally Bridge MedAlpha Master Fund L.P.

Fund registered in the Cayman Islands, based in New York, active since 2017. Summary from the record

Last updated Oct 21, 2026.

Overview

HeadquartersNew York, United States²
Legal formexempted limited partnership²
Kind of organizationFund²
LEI549300IC2QS0YN2W4U17²
StatusActive²
LEI statusLapsed (not renewed)²
Registered addressSouth Church Street, Ugland House, P. O. Box 309, KY1-1104 George Town, Grand Cayman, Cayman Islands²
Registered withGeneral Registry, 92753²

See how the biggest companies compare on our leaderboards

Corporate structure

Ally Bridge MedAlpha Master Fund L.P. sits at the top of its group. 4 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Ally Bridge MedAlpha Master Fund L.P. New York, New York, United States
- Cogent Biosciences, Inc. Stake · Waltham, Massachusetts
- Syros Pharmaceuticals, Inc. Stake · Cambridge, Massachusetts, United States
- Viridian Therapeutics, Inc.\DE Stake · Waltham, Massachusetts

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); stakes of 5% or more it reported on Schedules 13D and 13G (3 companies). Each entity in the chart links to its source.

Timeline

Oct 10, 2017Founded Ally Bridge MedAlpha Master Fund L.P. is founded²

Stakes it holds

Ally Bridge MedAlpha Master Fund L.P. has told the SEC it owns more than 5% of 3 companies, latest first (Schedules 13D and 13G).

Syros Pharmaceuticals, Inc.SC 13G/A Feb 11, 2022 to Feb 13, 2024³
Cogent Biosciences, Inc.SC 13G/A Feb 11, 2022⁴
Viridian Therapeutics, Inc.\DESC 13G/A Feb 11, 2022⁵

Sources

The numbers on this page point here. Each one links to the record it came from.